AMICUS THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.765 USD | -1.96% |
|
-0.91% | -31.08% |
Chart calendar Amicus Therapeutics, Inc.
62fee34e76.KTzq4q3GkrU1S48wQLeaxu-Q2MKQg1J4YMDlWMQ3XTE.bE-frOKC6_t7CvxxLOW3jMKgvO-9siY9DPKjNadfGUZDdaiXwLfi33s55A~45fd546ea5b8a221565092e99a3f484e
Upcoming events on Amicus Therapeutics, Inc.
Past events on Amicus Therapeutics, Inc.
| 2024-11-19 03:00 am | Jefferies London Healthcare Conference |
| 2024-11-12 | JPM Equity Opportunity Forum |
| 2024-11-12 02:30 pm | Guggenheim Securities Healthcare Innovation Conference |
| 2024-11-06 08:30 am | Q3 2024 Earnings Call |
| 2024-11-06 07:00 am | Q3 2024 Earnings Release |
| 2024-10-11 09:45 am | Congress of the World Muscle Society - Poster #657P |
| 2024-10-11 09:45 am | Congress of the World Muscle Society - Poster #670P |
| 2024-10-11 09:45 am | Congress of the World Muscle Society - Poster #671P |
| 2024-09-17 01:55 pm | Cantor Global Healthcare Conference |
| 2024-09-05 10:00 am | Morgan Stanley Healthcare Conference |
| 2024-09-05 07:10 am | Society for the Study of Inborn Errors of Metabolism Symposium |
| 2024-09-04 01:15 pm | Society for the Study of Inborn Errors of Metabolism Symposium - Poster No #20863 |
| 2024-09-04 01:15 pm | Society for the Study of Inborn Errors of Metabolism Symposium - Poster No #20873 |
| 2024-09-04 01:15 pm | Society for the Study of Inborn Errors of Metabolism Symposium - Poster No #20789 |
| 2024-09-04 01:15 pm | Society for the Study of Inborn Errors of Metabolism Symposium - Poster No #21202 |
| 2024-09-04 01:15 am | Society for the Study of Inborn Errors of Metabolism Symposium - Poster No #21180 |
| 2024-08-08 08:30 am | Q2 2024 Earnings Call |
| 2024-08-08 07:00 am | Q2 2024 Earnings Release |
| 2024-06-11 04:00 pm | Goldman Sachs Global Healthcare Conference - Fireside Chat |
| 2024-06-06 09:00 am | Annual General Meeting |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 306 307 -0.39% | 329 329 0.1% | 399 399 0% | 526 | 640 | 796 |
|
EBITDA Million USD | Released Forecast Spread | -200 -169 -18.19% | -207 -183 -13.17% | -69,3 -67,8 -2.22% | 32,9 | 123 | 211 |
|
EBIT Million USD | Released Forecast Spread | -206 -172 -19.97% | -212 -195 -8.52% | -77,2 -79,4 2.74% | 29,6 | 109 | 213 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -242 -199 -21.26% | -242 -216 -12.2% | -150 -133 -12.49% | -28,6 | 58,1 | 180 |
|
Net income Million USD | Released Forecast Spread | -250 -205 -21.99% | -237 -223 -6.06% | -152 -133 -14.32% | -60,9 | 45,1 | 160 |
|
EPS USD | Released Forecast Spread | -0,92 -0,76 -20.7% | -0,82 -0,77 -5.87% | -0,51 -0,45 -13.36% | -0,20 | 0,15 | 0,51 |
| Announcement Date | 24/02/22 | 01/03/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 86,3 83,2 3.68% | 94,5 89,9 5.16% | 104 101 2.1% | 115 115 0.03% | 110 111 -0.7% | 127 121 4.47% | 142 135 4.86% | 147 | 142 | 154 | 167 | 180 | 168 | 178 | 187 |
|
EBITDA Million USD | Released Forecast Spread | -36,4 -30,5 -19.25% | -16,7 -22,9 27.42% | -14,8 -10,0 -47.28% | -1,51 -19,9 92.43% | -25,6 -14,4 -78.15% | 17,1 -8,95 291.55% | 12,0 | ||||||||
|
EBIT Million USD | Released Forecast Spread | -37,6 -36,0 -4.63% | -18,9 -23,3 19.14% | -17,0 -9,86 -72.61% | -3,69 -5,70 35.23% | -27,7 -8,68 -219.39% | 15,0 -3,35 546.75% | 21,7 14,9 45.77% | 20,1 | 10,2 | 22,7 | 29,3 | 40,3 | |||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -53,2 -44,3 -20.12% | -40,5 -32,4 -24.96% | -24,7 -21,6 -14.23% | -31,7 -15,4 -105.44% | -43,6 -18,5 -135.95% | 0,11 -15,5 100.7% | 6,79 2,22 204.96% | 9,45 | 2,55 | 9,93 | 17,6 | 29,3 | |||
|
Net income Million USD | Released Forecast Spread | -52,9 -41,0 -28.99% | -43,2 -33,2 -30.07% | -21,6 -21,6 0.19% | -33,8 -17,0 -99.21% | -48,4 -19,7 -145.93% | -15,7 -17,3 9.23% | -6,73 0,18 -3868.9% | 5,74 | -1,15 | 6,20 | 13,5 | 24,5 | |||
|
EPS USD | Released Forecast Spread | -0,18 -0,15 -20.88% | -0,15 -0,11 -31.94% | -0,07 -0,08 7.2% | -0,11 -0,06 -87.43% | -0,16 -0,06 -148.29% | -0,05 -0,06 9.57% | -0,02 0,00 -1794.92% | 0,02 | 0,00 | 0,03 | 0,05 | 0,08 | |||
| Announcement Date | 10/05/23 | 08/08/23 | 08/11/23 | 28/02/24 | 09/05/24 | 08/08/24 | 06/11/24 | - | - | - | - | - | - | - | - |
More events
Past sector events for Amicus Therapeutics, Inc.
| 2024-11-27 | FORMYCON AG: Q3 2024 Earnings Release |
| 2024-11-20 07:00 am | SEPTERNA, INC.: Q3 2024 Earnings Release |
| 2024-11-20 02:00 am | GENUS PLC: Q1 2025 Sales and Revenue Release - Trading Update |
| 2024-11-19 | MESOBLAST LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-11-14 08:00 am | ARRIVENT BIOPHARMA, INC.: Q3 2024 Earnings Release |
| 2024-11-14 08:00 am | SILENCE THERAPEUTICS PLC: Q3 2024 Earnings Release |
| 2024-11-14 02:00 am | BIOARCTIC AB: Q3 2024 Earnings Release |
| 2024-11-13 | VORONOI, INC.: Q3 2024 Earnings Release |
| 2024-11-13 | GNI GROUP LTD.: Q3 2024 Earnings Release |
| 2024-11-13 04:10 pm | PHARVARIS N.V.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FOLD Stock
- Calendar Amicus Therapeutics, Inc.